Clinical Trial Update: A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

This is a clinical trial update for a Phase 2 study of BMS-512148 in Type 2 diabetes mellitus, noting that the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BMS-512148

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED